Readership: The book will primarily appeal to health economists, policy makers, analysts and researchers, but is also of interest to those studying social science, management, innovation, or technology, and those working in the pharmaceutical industry.
Edited by Joan Costa-Font, Senior Research Fellow and Lecturer, Health and Social Care Department, London School of Economics, UK, Christophe Courbage, Director of Research, The Geneva Association (International Association for the Study of Insurance Economics); Lecturer in Health Economics, Institute of Health Economics and Management, University of Lausanne, Switzerland, and Alistair McGuire, Professor of Health Economics and Health, Department of Social Policy, London School of Economics, UK
Part I. Introduction
1: Alistair McGuire & Victoria Serra: What do we know about the role of health care technology in driving healthcare expenditure growth?
Part II. Innovation, diffusion and technology change
2: Davide Consoli, Andrew McMeekin, J. Stan Metcalfe, Andrea Mina & Ronnie Ramlogan: The process of innovation: incentives, behaviour and organization
3: Nick Bosanquet: Technology - scientific force or power force?
4: Victoria Serra-Sastre & Alistair McGuire: Diffusion of health technologies: evidence from the pharmaceutical sector
Part III. Technological change and health insurance
5: Mark Pauly & Adam Isen: Insurance and new health technology
6: Peter Zweifel: Technological change and health insurance
7: Marin Gemmill, Victoria Serra & Joan Costa-Font: Health insurance and the uptake of new drugs in the United States
8: Lilia Filipova & Michael Hoy: Genetic advances and health insurance
Part IV. Innovation, social demand and valuation
9: Roland Eisen & Yasemin Ilgin: Ageing and pharmaceutical innovation
10: Manuel García-Goñi & Paul Windrum: New approaches to healthcare innovation: information for chronic patients
11: Nicola Pangher: The convergence of nano-, bio- and information technologies in healthcare
12: Joshua Graff Zivin, Matthew Neidell, & Lauri Feldman: Treatment uncertainty and irreversibility in medical care: implications for cost-effectiveness analysis
13: Adam Oliver & Corinna Sorenson: The limits and challenges to the economic evaluation of health technologies
Part V. Incentives, mechanisms and processes
14: Joan Rovira: Intellectual property rights and pharmaceuticals development
15: Frank R. Lichtenberg: Home, or nursing home? The effect of medical innovation on the demand for long-term care
16: Joan Costa-Font, Caroline Rudisill & Elias Mossialos: Demand for health information on the internet
17: Hristina Petkova: Institutional pathways for integrating genetic testing into mainstream healthcare